These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22632818)

  • 1. Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation.
    Zhao YD; Cai L; Mirza MK; Huang X; Geenen DL; Hofmann F; Yuan JX; Zhao YY
    Am J Pathol; 2012 Jun; 180(6):2268-75. PubMed ID: 22632818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
    Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
    Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil.
    Dai ZK; Wu BN; Chen IC; Chai CY; Wu JR; Chou SH; Yeh JL; Chen IJ; Tan MS
    Pediatr Pulmonol; 2011 Jan; 46(1):45-59. PubMed ID: 20717937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKG-1α leucine zipper domain defect increases pulmonary vascular tone: implications in hypoxic pulmonary hypertension.
    Ramchandran R; Raghavan A; Geenen D; Sun M; Bach L; Yang Q; Raj JU
    Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(7):L537-44. PubMed ID: 25128522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.
    Barman SA; Zhu S; White RE
    Vasc Health Risk Manag; 2009; 5():663-71. PubMed ID: 19707285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
    Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
    Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: role of protein kinase G nitration.
    Aggarwal S; Gross CM; Kumar S; Datar S; Oishi P; Kalkan G; Schreiber C; Fratz S; Fineman JR; Black SM
    J Cell Physiol; 2011 Dec; 226(12):3104-13. PubMed ID: 21351102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
    Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
    Li FH; Xia W; Sun RP
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.
    Nagaoka T; Gebb SA; Karoor V; Homma N; Morris KG; McMurtry IF; Oka M
    J Appl Physiol (1985); 2006 Mar; 100(3):996-1002. PubMed ID: 16322374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho kinase-mediated vasoconstriction in pulmonary hypertension.
    McMurtry IF; Abe K; Ota H; Fagan KA; Oka M
    Adv Exp Med Biol; 2010; 661():299-308. PubMed ID: 20204738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia.
    Wojciak-Stothard B; Zhao L; Oliver E; Dubois O; Wu Y; Kardassis D; Vasilaki E; Huang M; Mitchell JA; Harrington LS; Prendergast GC; Wilkins MR
    Circ Res; 2012 May; 110(11):1423-34. PubMed ID: 22539766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors.
    Fukumoto Y; Tawara S; Shimokawa H
    Tohoku J Exp Med; 2007 Apr; 211(4):309-20. PubMed ID: 17409670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.